- Article
Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
- Ling Ding,
- Yuning Yang,
- Yang Ge,
- Qin Lu,
- Zixing Yan,
- Xuzheng Chen,
- Jian Du,
- Sassan Hafizi,
- Xiaohui Xu and
- Nathaniel Weygant
- + 3 authors
The approval of immune checkpoint inhibitors has expanded treatment options for renal cell carcinoma (RCC), but new therapies that target RCC stemness and promote anti-tumor immunity are needed. Previous findings demonstrate that doublecortin-like ki...